BNP Paribas Knock-Out GSK!OLD1/ DE000PH7FPV1 /
5/17/2022 8:20:11 AM | Chg.+0.52 | Bid12:03:45 PM | Ask12:03:45 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.56EUR | +12.87% | 4.60 Bid Size: 1,000 |
4.61 Ask Size: 1,000 |
Glaxosmithkline PLC ... | 14.1339 GBP | 12/31/2078 | Call |
GlobeNewswire
3/25
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA...
GlobeNewswire
2/28
Surface Oncology to Participate in Novel Immuno-Oncology Panel at Cowen’s 42nd Annual Health Care Co...
GlobeNewswire
2/28
Cullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones,...
GlobeNewswire
2/10
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2
GlobeNewswire
12/14/2021
Preclinical Data Highlight the Significant Antigenic Shift of the Omicron SARS-CoV-2 Variant and its...